DCOY is trading at $7.67 (up 6.7%) as shares rebound from a sharp two-day pullback following the financing-driven rally on June 29.

  • The recent surge was sparked by Decoy Therapeutics securing up to $21 million in funding to support clinical trials.
  • After hitting a peak, the stock faced profit-taking on June 30, making today's move a partial recovery as volatility continues around the financing news.